Alan A. Musso
Board Member
Rein Therapeutics, Inc. (RNTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alan A. Musso
Alan A. Musso is recorded as Board Member at Rein Therapeutics, Inc. (RNTX). Rein Therapeutics, Inc. reported in an 8-K filed October 31, 2023 that Alan A. Musso was appointed Director. Rein Therapeutics, Inc. reported in an 8-K filed October 31, 2023 that Alan A. Musso was appointed Director, effective October 31, 2023.
“two directors from Lung Tx who have been appointed to the Aileron Board: William C. Fairey and Alan A. Musso”
“on October 30, 2023, the Board decreased the size of the Board by one member, effective as of the Effective Time, such that the number of directors that comprised the full Board was six (6), and elected William C. Fairey, age 59, and Alan A. Musso, age 61, to the Board as directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor CEO, COO, Board Member
- Brian Windsor, Ph.D. CEO, COO, Board Member
- Josef H. von Rickenbach Chairman, Board Member
- Charles Garner CFO
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
- Reinhard J. Ambros Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.